|1.||Zagonel, V: 1 article (02/2001)|
|2.||Tirelli, U: 1 article (02/2001)|
|3.||Monfardini, S: 1 article (02/2001)|
|4.||Carbone, A: 1 article (02/2001)|
|5.||Langdon, S P: 1 article (01/2001)|
|6.||Lawrie, S S: 1 article (01/2001)|
|7.||Pungolino, E: 1 article (08/2000)|
|8.||Nosari, A: 1 article (08/2000)|
|9.||Bernuzzi, P: 1 article (08/2000)|
|10.||Santoleri, L: 1 article (08/2000)|
|1.||Hodgkin Disease (Hodgkin's Disease)
05/29/1994 - "[Treatment of advanced stage Hodgkin disease with CCNU, etoposide and prednimustine (CEP)]."
01/01/1991 - "Treatment of resistant Hodgkin's disease with CCNU, etoposide and prednimustine (CEP)."
01/01/1990 - "Treatment of advanced Hodgkin's disease with lomustine, etoposide, and prednimustine."
06/01/1988 - "[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. "
05/01/1986 - "These results indicate that lomustine, etoposide, and prednimustine can play a role in the treatment of advanced resistant Hodgkin's disease."
|2.||Breast Neoplasms (Breast Cancer)
03/01/1986 - "Mature results from these studies are needed to define the future role of prednimustine in the systemic therapy of breast cancer."
07/15/1980 - "Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer."
03/01/1986 - "Prednimustine in advanced breast cancer: a review."
07/15/1980 - "The therapeutic effect of prednimustine was studied in 35 patients with advanced breast cancer resistant to previous cytotoxic and/or endocrine therapy. "
11/01/1987 - "Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer."
|3.||Non-Hodgkin Lymphoma (Lymphosarcoma)
03/01/1986 - "Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group."
01/01/1993 - "Continuous versus intermittent prednimustine treatment of non-Hodgkin's lymphoma."
01/01/1991 - "Combined total body irradiation (TBI) and Prednimustine were prospectively evaluated in 30 patients affected either with chronic lymphocytic leukemia (CLL) or with low-grade non-Hodgkin's lymphoma (NHL) eleven patients were previously treated. "
06/01/1988 - "Mitoxantrone in combination with prednimustine in treatment of unfavorable non-Hodgkin lymphoma."
06/01/1977 - "In a phase II trial, prednimustine was often efficient in treating chronic lymphoid leukaemia (CLL) patients and was also active in some patients with lymphosarcoma, melanoma and bronchus carcinoma. "
07/01/1982 - "Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report."
03/01/1986 - "Prednimustine is active against a wide variety of experimental tumors both in vivo and in vitro. "
01/01/1977 - "Determination of glucocorticoid binding capacity or Prednimustine uptake might predict the effectiveness of Prednimustine in the treatment of tumor. "
03/01/1997 - "Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. "
03/01/1997 - "Newly diagnosed follicular lymphoma patients with a low tumor burden (n = 193) were randomly assigned to one of three arms: arm 1, no initial treatment (n = 66); arm 2, prednimustine 200 mg/m2/d for 5 days per month for 18 months (n = 64); or arm 3, interferon alfa 5 MU/d for 3 months then 5 MU three times per week for 15 months (n = 63). "
01/01/1989 - "Results from clinical trials confirm that prednimustine is active in malignant lymphomas. "
01/01/1993 - "Our results suggest that prednimustine in non-Hodgkin's lymphomas has similar effectiveness both in daily treatment and in a two-weekly intermittent schedule. "
01/01/1989 - "Prednimustine treatment in malignant lymphomas."
01/01/1985 - "Value of prednimustine in treating non Hodgkin's lymphomas of favourable histological type."
01/01/1978 - "The effect of Prednimustine was evaluated in 37 patients with generalised non-Hodgkin's lymphomas. "
|5.||Etoposide (VP 16)
|1.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|2.||Drug Therapy (Chemotherapy)
|3.||Combination Drug Therapy (Combination Chemotherapy)